Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (211-220 of 347) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Molecular staging of intracranial ependymoma in children and adultsAndrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
Oncoimmunology|June 7, 2018
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trialJudith Michels, Natalia Becker, Stefan Suciu, et al.
Cancer Research|June 13, 2015
A Systematic Approach to Defining the microRNA Landscape in MetastasisGiridhar Mudduluru, Mohammed Abba, Jasmin Batliner, et al.
British Journal of Haematology|October 10, 2015
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trialMathias Witzens-Harig, Axel Benner, Fabienne McClanahan, et al.
International Journal of Cancer|February 3, 2016
SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patientsElisabeth J Kap, Petra Seibold, Dominique Scherer, et al.
Haematologica|March 18, 2021
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patientsJohannes Bloehdorn, Julia Krzykalla, Karlheinz Holzmann, et al.
International Journal of Cancer|March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myelomaJens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancerDharanija Madhavan, Manuela Zucknick, Markus Wallwiener, et al.
Blood|February 12, 2011
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.
Pageof 35

Showing results (211-220 of 347) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Molecular staging of intracranial ependymoma in children and adultsAndrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemiaTilmann Bochtler, Friedrich Stölzel, Christoph E Heilig, et al.
Oncoimmunology|June 7, 2018
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trialJudith Michels, Natalia Becker, Stefan Suciu, et al.
Cancer Research|June 13, 2015
A Systematic Approach to Defining the microRNA Landscape in MetastasisGiridhar Mudduluru, Mohammed Abba, Jasmin Batliner, et al.
British Journal of Haematology|October 10, 2015
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trialMathias Witzens-Harig, Axel Benner, Fabienne McClanahan, et al.
International Journal of Cancer|February 3, 2016
SNPs in transporter and metabolizing genes as predictive markers for oxaliplatin treatment in colorectal cancer patientsElisabeth J Kap, Petra Seibold, Dominique Scherer, et al.
Haematologica|March 18, 2021
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patientsJohannes Bloehdorn, Julia Krzykalla, Karlheinz Holzmann, et al.
International Journal of Cancer|March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myelomaJens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancerDharanija Madhavan, Manuela Zucknick, Markus Wallwiener, et al.
Blood|February 12, 2011
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.
Pageof 35